- Home
- FSEA vs LTRN Comparison
FSEA vs LTRN Comparison
Compare FSEA & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSEA
- LTRN
- Stock Information
- Founded
- FSEA 1890
- LTRN 2013
- Country
- FSEA United States
- LTRN United States
- Employees
- FSEA N/A
- LTRN N/A
- Industry
- FSEA Savings Institutions
- LTRN Biotechnology: Pharmaceutical Preparations
- Sector
- FSEA Finance
- LTRN Health Care
- Exchange
- FSEA Nasdaq
- LTRN Nasdaq
- Market Cap
- FSEA 47.0M
- LTRN 46.7M
- IPO Year
- FSEA N/A
- LTRN 2020
- Fundamental
- Price
- FSEA $10.82
- LTRN $4.33
- Analyst Decision
- FSEA
- LTRN Hold
- Analyst Count
- FSEA 0
- LTRN 1
- Target Price
- FSEA N/A
- LTRN N/A
- AVG Volume (30 Days)
- FSEA 12.1K
- LTRN 169.9K
- Earning Date
- FSEA 03-28-2025
- LTRN 03-17-2025
- Dividend Yield
- FSEA N/A
- LTRN N/A
- EPS Growth
- FSEA N/A
- LTRN N/A
- EPS
- FSEA N/A
- LTRN N/A
- Revenue
- FSEA $11,390,000.00
- LTRN N/A
- Revenue This Year
- FSEA N/A
- LTRN N/A
- Revenue Next Year
- FSEA N/A
- LTRN N/A
- P/E Ratio
- FSEA N/A
- LTRN N/A
- Revenue Growth
- FSEA N/A
- LTRN N/A
- 52 Week Low
- FSEA $8.05
- LTRN $2.79
- 52 Week High
- FSEA $11.30
- LTRN $11.99
- Technical
- Relative Strength Index (RSI)
- FSEA 67.92
- LTRN 46.51
- Support Level
- FSEA $10.31
- LTRN $4.15
- Resistance Level
- FSEA $10.97
- LTRN $4.79
- Average True Range (ATR)
- FSEA 0.24
- LTRN 0.45
- MACD
- FSEA 0.04
- LTRN -0.11
- Stochastic Oscillator
- FSEA 59.82
- LTRN 11.50
About FSEA First Seacoast Bancorp Inc.
First Seacoast Bancorp Inc is a savings and loan holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one-to-four-family residential real estate loans, commercial real estate, and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. The company generates revenue from financial instruments, such as loans, letters of credit, and investment securities, as well as revenue related to mortgage servicing activities and bank-owned life insurance.
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.